Holen Sie sich die Stockscreener-App
3.12
0.16%
-0.010
Schlusskurs vom Vortag:
$3.13
Offen:
$3.12
24-Stunden-Volumen:
2.63M
Relative Volume:
0.45
Marktkapitalisierung:
$1.30B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-11.72
EPS:
-0.2663
Netto-Cashflow:
$-178.21M
1W Leistung:
-2.04%
1M Leistung:
-8.09%
6M Leistung:
-10.20%
1J Leistung:
+174.12%
1-Tages-Spanne:
$3.0913
$3.16
1-Wochen-Bereich:
$3.09
$3.28
52-Wochen-Spanne:
$0.9001
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Vergleichen Sie CLOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
3.12 | 1.67B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
303.40 | 269.12B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
387.52 | 86.87B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
316.02 | 83.53B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
63.70 | 76.18B | 378.96B | 5.28B | 5.94B | 4.19 |
|
CNC
Centene Corp
|
56.83 | 28.90B | 163.07B | 3.31B | -490.00M | 6.24 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - The Globe and Mail
CLOV Joins Russell 3000 Index Amid Annual Reconstitution - GuruFocus
Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit - Seeking Alpha
Here's Why Encompass Health Shares Are Attracting Investors Now - TradingView
AI Tools Are Getting FDA Attention—and Investors Are Taking Note - Baystreet.ca
CLOV Q1 Earnings Call: Membership Growth and Technology Drive Profitability Above Expectations - Yahoo Finance
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year? - Yahoo Finance
Transcript : Clover Health Investments, Corp. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Clover Health and Aviana Healthcare at Bank of America Conference: Strategic Growth Plans - Investing.com Nigeria
Clover Health sees AI platform as key to long-term growth - The Business Journals
Clover Health responds to shareholder queries By Investing.com - Investing.com India
Clover Health Prepares for Q1 2025 Earnings Release - TipRanks
Clover Health responds to shareholder queries - Investing.com
All You Need to Know About Clover Health Investments (CLOV) Rating Upgrade to Strong Buy - Yahoo Finance
Clover Health targets 30% Medicare Advantage growth and raises 2025 EBITDA guidance - MSN
Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026 (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments, Corp. (NASDAQ:CLOV) Stock Holdings Reduced by Wells Fargo & Company MN - Defense World
Decoding Clover Health Investments Corp (CLOV): A Strategic SWOT Insight - GuruFocus
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Investments And 2 Other Growth Stocks With Strong Insider Confidence - simplywall.st
Clover Health Investments, Corp. (NASDAQ:CLOV) Could Be Riskier Than It Looks - simplywall.st
Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results - simplywall.st
Clover Health Investments, Corp.'s (NASDAQ:CLOV) market cap rose US$220m last week; individual investors who hold 59% profited and so did insiders - Yahoo Finance
Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates - MSN
CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y - MSN
Clover Health’s Earnings Call Highlights Growth and Optimism - TipRanks
Clover Health Shares Surge After Strong Q1 Earnings, Now Up 409% Over Past Year - Benzinga
Clover Health Investments: Strong Performance and Growth Potential Justify Buy Rating - TipRanks
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call Highlights: Record Growth in ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call Highlights: Record Growth in ... By GuruFocus - Investing.com Canada
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Call Highlights: Record Growth in Revenue and Membership - GuruFocus
Clover Health Sees Strong Growth in Q1 2025 - TipRanks
Clover Health (CLOV) Sees Strong Growth in Q1 2025 - GuruFocus
Clover Health Investments earnings beat by $0.09, revenue fell short of estimates By Investing.com - Investing.com
Clover Health Investments, Corp. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:CLOV) - Seeking Alpha
Earnings call transcript: Clover Health’s Q1 2025 revenue surges, stock ticks up - Investing.com
Clover Health (CLOV) Delivers Strong Q1 2025 Financial Performance | CLOV Stock News - GuruFocus
CLOV Reports Q1 Revenue Slightly Below Expectations Amid Growth in Membership | CLOV Stock News - GuruFocus
Clover Health (CLOV) Reports Strong Profit Growth Despite Revenue Miss - GuruFocus
Clover Health Q1 2025 slides: Revenue surges 34%, adjusted EBITDA up 279% - Investing.com
Clover Health (CLOV) Q1 2025 Earnings: EPS of -$0.07 Meets Estimates, Revenue of $462M Misses Expectations - GuruFocus
Earnings Flash (CLOV) Clover Health Investments Reports Q1 Revenue $462M, vs. FactSet Est of $466.9M - marketscreener.com
Clover Health Q1 2025 slides: Revenue surges 34%, adjusted EBITDA up 279% By Investing.com - Investing.com South Africa
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance - The Manila Times
CLOV Anticipates Higher Volatility Ahead of Earnings Release | CLOV Stock News - GuruFocus
Clover Health (NASDAQ:CLOV) Misses Q1 Sales Targets - Barchart.com
Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare - Quantisnow
Clover Health (CLOV) Prepares for Q1 Earnings with Revenue Growt - GuruFocus
Clover Health (CLOV) Prepares for Q1 Earnings with Revenue Growth Expectations - GuruFocus
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance - ADVFN
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clover Health Investments Corp-Aktie (CLOV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Priest Brady Patrick | CEO of Home Care |
Mar 06 '25 |
Sale |
3.68 |
75,000 |
276,000 |
2,418,151 |
| Soares Karen | General Counsel & Secretary |
Mar 06 '25 |
Sale |
3.80 |
52,500 |
199,500 |
1,299,663 |
0.42%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):